Becton DickinsonBDX +2.44%76 EPS without NRI is $13.44 as of Mar. 2026. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 667 Medical Devices & Instruments companies, Becton Dickinson ranks better than 50.52% on this metric.
Becton Dickinson's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $2.90.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $13.44.
During the past 12 months, Becton Dickinson's average earnings per share (NRI) Growth Rate was -4.60% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 8.30% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 5.30% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 5.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Becton Dickinson's EPS without NRI or its related term are showing as below:
BDX'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -1 Med: 10.4 Max: 21.3
Current: 8.3
During the past 13 years, Becton Dickinson's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 21.30% per year. The lowest was -1.00% per year. And the median was 10.40% per year.
BDX's 3-Year EPS without NRI Growth Rate is ranked better than 50.52% of 667
companies
in the Medical Devices & Instruments industry
Industry Median: 8.1
vs BDX: 8.30
Becton Dickinson's EPS (Diluted) for the
three
months ended in Mar. 2026 was $-1.11.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.95.
Becton Dickinson's EPS (Basic) for the
three
months ended in Mar. 2026 was $-1.11.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.95.
Becton Dickinson (NYSE:BDX) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Becton Dickinson EPS without NRI Related Terms
Becton Dickinson EPS without NRI Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (BDX) has a EPS without NRI of $13.44 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Becton Dickinson and its competitors. According to the industry distribution chart, Becton Dickinson ranks #330 out of 667 companies in the Medical Devices & Instruments industry, placing it in the top 49.5%.
Is Becton Dickinson's EPS without NRI too high?
Becton Dickinson's current EPS without NRI is $13.44. The Medical Devices & Instruments industry median EPS without NRI is 8.10. Becton Dickinson's value of $13.44 is 65.9% above this industry median. Based on the distribution chart, Becton Dickinson ranks #330 out of 667 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's EPS without NRI compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #330 out of 667 companies for EPS without NRI. This puts Becton Dickinson in the upper half of its industry. The industry median EPS without NRI is 8.10. Becton Dickinson's value of $13.44 is 65.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.10, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current EPS without NRI of $13.44 is 65.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current EPS without NRI is $13.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current EPS without NRI is $13.44 and 65.9% above the Medical Devices & Instruments industry median of 8.10. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Becton Dickinson (BDX), the current EPS without NRI is $13.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for BDX:
EPS without NRI: $13.44
GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
Industry Position: 65.9% above the Medical Devices & Instruments median (#330 of 667)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score
Get the complete analysis for BDX
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
